Skip to content

Effectiveness of Two Maxillary Expanders in Improving the Transverse Skeletal and Dental Dimensions in Patients With Cleft Lip and Palate

Effectiveness of Two Rapid Maxillary Expanders (Quadhelix vs Hyrax) in Improving the Transverse Skeletal and Dental Dimensions in Patients With Cleft Lip and Palate: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04331977
Enrollment
24
Registered
2020-04-02
Start date
2020-07-02
Completion date
2022-12-30
Last updated
2023-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Lip and Palate, Maxillary Expansion

Brief summary

This randomized controlled trial is designed to compare between quadlelix appliance vs hyrax expander regrading the their effectiveness in maxillary expansion in patients with cleft.

Interventions

DEVICEMaxillary Expansion

2 appliances to expand the maxillary arch

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Mixed dentition stage; * Both males and females; * Lip repair performed between 3 and 6 months of age and palate repair performed between 12 and 24 months of age; * Presence of maxillary constriction and posterior crossbite and need for maxillary expansion previous to the secondary bone graft; * Permanent first maxillary molars present; * Good periodontal health; * No previous orthodontic treatment; and

Exclusion criteria

* Presence of a syndrome in companion with the present cleft defect. * Previous secondary alveolar bone grafting. * Taking medications affecting growth.

Design outcomes

Primary

MeasureTime frameDescription
Maxillary Expansion6 monthsAmount of Maxillary Expansion to be measured as distances (mm) on CBCTs and dental models.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026